Favism is an acute hemolytic anemia known to occur in susceptible individuals who ingest fava beans. Susceptibility to favism is conferred by a genetic deficiency in erythrocytic glucose-6-phosphate dehydrogenase (G6PD) activity. Although the fava bean pyrimidine aglycones, divicine and isouramil, have been implicated in the onset of favism in humans, the lack of a well-defined experimental animal model for favism has hampered progress in elucidating the mechanism underlying hemotoxicity. We have examined whether a favic-like response could be provoked in G6PD-normal rats treated with synthetic divicine. Intraperitoneal administration of divicine to rats preloaded with 51 Cr-tagged erythrocytes resulted in a severe, dose-dependent decrease in blood radioactivity (TD 50 ϳ0.5 mmol/kg) within 24 h. The increased rate of removal of blood radioactivity was accompanied by a rapid decline in reduced glutathione levels in the blood, decreased hematocrits, marked hemoglobinuria, splenic enlargement, and reticulocytosis. In vitro exposure of 51 Cr-tagged red cells to divicine before their re-administration to isologous rats also resulted in a sharp, concentration-dependent decrease in erythrocyte survival in vivo (TC 50 ϳ1.5 mM), and these divicine-damaged red cells were removed from the circulation by the spleen. These data demonstrate that a favic response can be induced in G6PD-normal rats treated with divicine, and that hemolytic activity can be reproduced in isolated red cells under conditions that will allow a direct examination of the mechanism underlying this hemotoxicity.
Favism is a potentially life-threatening hemolytic anemia that can result from the ingestion of fava beans (Vicia faba) by individuals with low-activity variants of erythrocytic glucose 6-phosphate dehydrogenase (G6PD). Two fava bean pyrimidines, divicine and isouramil, have been implicated in the onset of favism primarily on the basis of their ability to deplete reduced glutathione (GSH) in suspensions of human G6PD-deficient red cells (Mager et al., 1965) . Divicine and isouramil are not present in fava beans per se, but are contained as the chemically inactive ␤-glucosides, vicine and convicine, respectively. The mechanism underlying the onset of favism is not understood. It has been postulated that both pyrimidine aglycones, liberated upon digestion of their parent glucosides (Hegazy and Marquardt, 1984) , are absorbed into the blood and induce oxidative damage within erythrocytes as a consequence of redox cycling (Chevion et al., 1982; Winterbourn and Munday, 1990) .
One problem that has hampered progress in research on favism over the years has been the lack of a favism-susceptible experimental animal model (Beutler, 1978) . Currently there are no commercially available G6PD-deficient laboratory animals, and efforts to induce favism in rodents given vicine and convicine have been unsuccessful (Yannai and Marquardt, 1985) . Thus, most of the information on favism is derived from the following types of experimental approaches: (1) examination of red cells isolated from patients during favic episodes (Gaetani et al., 1979) ; (2) assessment of cellular changes induced by incubation of isolated red cell suspensions with the pyrimidines; and (3) assessment of the chemical reactivity of the pyrimidines in acellular systems (for reviews, see Arese, 1982; Arese et al., 1989) . Although these approaches have provided evidence strengthening the association between fava bean pyrimidine-induced oxidative red cell damage and the onset of favism, the significance of many of these observations to the hemolytic event in vivo remains to be established.
Moreover, because convicine and isouramil are not commercially available, most of the research in this area has been done with divicine. This pyrimidine is unstable in the presence of oxygen and hence is typically prepared from commercially available vicine in small amounts for immediate experimental use. The validity of much of the information derived from these studies has been questioned, however, because the most commonly employed method of preparing divicine, chemical hydrolysis of vicine in hydrochloric acid at 100°C, was shown to yield a deaminated derivative of divicine with different chemical reactivity (Pedersen et al., 1988) .
We have overcome these problems by using a direct synthetic method (Bailey et al., 1982) to prepare divicine of high purity, and have shown that it is a direct-acting hemolytic agent in rat red cells; that is, incubation of divicine with 51 Cr-labeled rat red cells in vitro followed by re-administration of the labeled cells to isologous rats increases the rate of removal of the radiolabeled cells from the circulation as compared to saline-treated control red cells (McMillan et al., 1993) . These data raised the possibility that the rat could serve as a useful experimental model in which to resolve the mechanism underlying favism. Thus, the purpose of the present study was twofold: (1) to determine whether a favic-like response could be provoked in vivo by administration of synthetic divicine to G6PD-normal rats; and (2) to establish experimental conditions under which cellular alterations induced by in vitro exposure to divicine could be correlated with decreased erythrocyte survival in vivo. We report that divicine can indeed induce a favic response in G6PD-normal rats, if the dose of divicine is sufficiently high. Furthermore, the hemolytic activity of divicine observed in vivo can be reproduced in vitro, which will allow an assessment of the relevance of divicine-induced biochemical and cellular changes to the hemotoxic response.
MATERIALS AND METHODS
Chemicals and materials. Divicine (2,6-diamino-5-hydroxy-4[3H]-pyrimidinone) hemisulfate was synthesized as described previously (Bailey et al., 1982) . Divicine hemisulfate was converted to divicine hydrochloride with barium chloride, and stored under argon at -20°C. Purity of the synthetic divicine was Ͼ99% as judged by HPLC, and mass and NMR spectral analysis (McMillan et al., 1993) . The concentration of divicine (hydroquinone form) in stock solutions was monitored by measuring the reduction of ferriphenanthroline as described previously (Chevion and Navok, 1983) . Na 2 51 CrO 4 in sterile saline (1 mCi/ml, pH 8) was purchased from New England Nuclear (Billerica, MA). All other chemicals and reagents were of the best commercially available grade.
Animals. Male Sprague-Dawley rats (130 -150 g) were purchased from Harlan Laboratories (Indianapolis, IN), and maintained on food and water ad libitum. Animals were acclimated for 1 week to a 12-h light/dark cycle prior to the experiment.
Measurement of the hemolytic response.
To determine the hemolytic activity of divicine in vivo, rat red cells were collected, tagged with 51 Cr (0.1 mCi/ml of packed red cells), and administered iv to isologous rats as described previously (Harrison and Jollow, 1986) . Twenty-four h after administration of the labeled cells, a 75 l blood sample (T 0 ) was taken from the orbital sinus, followed immediately by ip administration of divicine hydrochloride dissolved in argon-purged, phosphate-buffered saline (5 ml/kg, pH 7). Serial blood samples were collected from each rat at 0.5, 1, 2, 4, and 7 days. At the end of the experiment, all the blood samples were counted concurrently in a well-type gamma counter, with the counts above background for each sample expressed as a percentage of the T 0 sample. Preliminary examination of the data on a semi-log plot revealed single-compartment (first-order) kinetics of red cell elimination. The time for blood radioactivity in serial samples to decrease to 50% of initial levels ( 51 Cr-T 50 ) was determined for each animal by regression analysis, as described by the International Committee on Standardization in Hematology (ICSH, 1980) . The mean percentage reduction in 51 Cr-T 50 was then plotted against the log dose of divicine. Statistical analyses utilized Student's t-test for pooled samples.
Hematocrits, hemoglobinuria, and the percentage of circulating reticulocytes after divicine administration were determined as described previously (Bauer et al., 1974) . The concentration of GSH was determined in serial blood samples (75 l) from control and divicine-treated rats using HPLC with electrochemical detection, as described previously (Jensen et al., 1986) .
To determine the direct hemolytic activity of divicine, 51 Cr-labeled red cells (40% hematocrit) were incubated aerobically with various concentrations of divicine for 2 h at 37°C in isotonic phosphate-buffered saline (pH 7.4) supplemented with 10 mM D-glucose (PBSG). After the incubation period, the cells were washed once in PBSG, and administered intravenously to rats. A T 0 blood sample was taken from each rat 5 min after administration of the labeled cells, and additional samples were taken at 6, 12, 18, 24, and 48 h, and then on days 4 and 7. Preliminary examination of the data on semi-log plots revealed a 2-compartment model of red cell elimination. The fraction of the 51 Cr-labeled red cells that were subject to premature removal from the circulation was determined for each animal by extrapolation of the terminal-elimination-phase data points to the y-intercept. The mean y-intercept value for each treatment group was subtracted from 100, and this value was plotted against the log divicine concentration.
Disposition of the chromium label. The disposition of
51 Cr was examined in groups of rats that received radiolabeled red cells exposed to divicine in vitro, as described previously (Harrison and Jollow, 1986) . Divicine treatment and control groups (n ϭ 4 rats) were maintained in metabolic cages for the collection of urine, which was assayed for radioactivity and the presence of hemoglobin. At designated intervals, animals were weighed, and blood samples were taken for determination of blood radioactivity and hematocrit. After the blood samples were collected, the animals were sacrificed, and spleens, livers, kidneys, and muscle samples were removed, weighed, and stored. Urine, blood, and tissue samples were counted concurrently in a well-type gamma counter at the end of the experiment. The level of radioactivity in the tissues was corrected to account for 51 Cr activity of residual red cells within the tissue vasculature.
RESULTS

Divicine-Induced Hemolytic Anemia in theRat
To investigate the hemolytic potential of divicine in vivo, rats pre-loaded with 51 Cr-labeled red cells were administered various doses of divicine hydrochloride, and serial blood samples were taken for 7 days to allow determination of the time necessary for blood radioactivity to decrease to 50% of the T 0 value ( 51 Cr-T 50 ). As shown in Figure 1A , administration of the vehicle to control rats induced a gradual decline in blood radioactivity that is thought to primarily reflect elimination of senescent red cells by the spleen (Harrison and Jollow, 1986) . In contrast, administration of divicine resulted in a rapid, dose-dependent increase in the rate of elimination of radioactivity from the blood (Fig. 1A) , with attendant decreases in 51 Cr-T 50 values when compared to controls. Figure 1B shows the dose-dependence of the hemolytic response to divicine. The hemolytic response is plotted as the percentage decrease in 51 Cr-T 50 of the experimental animals relative to that of the mean control value. The dose range that defined the hemolytic response to divicine was quite narrow, with an apparent threshold dose of about 300 mol/kg, a TD 50 of about 500 mol/kg, and a maximally effective dose of about 850 mol/kg.
To determine whether divicine administration to rats is followed by hematologic alterations similar to those observed clinically during a favic episode, hematocrit, hemoglobinuria, and the extent of reticulocytosis were examined after divicine administration. As shown in Figure 2 , the increased rate of removal of blood radioactivity in divicine-treated rats was accompanied by significantly decreased hematocrits at the 2 highest doses (567 and 680 mol/kg). The drop in hematocrit in these animals was temporary and returned to near normal by day 7. In the highest dose group (850 mol/kg), 75% of the rats died within 24 h. Death occurred about 12 h after divicine administration and was associated with markedly depressed hematocrit values (ca 10%). The lack of an observable decrease in hematocrit following the 2 lowest divicine doses (223 and 453 mol/kg), despite declines in blood radioactivity (Fig.  1A) , reflects compensatory release of reticulocytes into the circulation of these animals to maintain normal red cell volume.
As shown in Figure 3 , the loss of circulating red cells from divicine-treated rats was accompanied by marked hemoglobinuria (Fig. 3A) within 12 to 24 h after exposure. By 48 h, there was an appearance of reticulocytes (Fig. 3B) . Red cell loss was also accompanied by a significant increase in spleen weight (Fig. 4) . Spleen weight and hematocrit appeared to reach a peak and nadir, respectively, 3 days after exposure to divicine. In contrast, liver weights in divicine-treated rats did not differ significantly from controls at any time during the course of the experiment (data not shown).
Effect of Divicine on Blood GSH Levels
A well recognized clinical characteristic observed during the course of a favic episode is instability of blood GSH (Gaetani et al., 1979) . To determine whether the hemolytic response to divicine was accompanied by GSH depletion, the concentration of GSH in serial blood samples from rats exposed to an EC 50 doses of divicine (500 mol/kg) was measured by HPLC with electrochemical detection. As shown in Figure 5 , divicine administration induced a rapid depletion of GSH in the blood (i.e., ϳ70% depletion within 30 min of exposure). Of note, this decrease in GSH was not due to loss of red cells from the circulation at these early time points, because the hematocrits in the divicine treatment groups were not significantly different from controls.
Effect of in Vitro Exposure to Divicine
We have shown previously that in vitro exposure of rat red cells to a single concentration of divicine (1.5 mM) for 2 h at 37°C results in a dramatic decrease in the survival of the treated cells upon their return to the circulation in isologous rats (McMillan et al., 1993) . The present studies demonstrate the concentration dependence of this response (Fig. 6A ). In agreement with the previous report noted above, 2 distinct phases of red cell elimination were readily apparent after in vitro exposure to divicine: (1) a concentration-dependent early phase of rapid removal of damaged cells within the first 24 h; and (2) a second phase of slow removal of senescent (presumably undamaged) red cells. Of note, the initial rate of red cell removal at divicine concentrations above 1.5 mM was sufficiently rapid that no differences in 51 Cr-T 50 s were observed. To quantitate the magnitude of the hemolytic response after in vitro exposure to divicine, the extent of hemolytic damage was expressed as the fraction of red cells that were removed within the first 24 h after exposure (Fig. 6B) . The concentration range that defined this response also was quite narrow, with an apparent threshold concentration of about 1.2 mM, an EC 50 of about 1.5 mM, and a maximally effective divicine concentration of about 2 mM.
Disposition of 51 Cr-labeled Red Cells after in Vitro Exposure to Divicine
The appearance of hemoglobinurea and free hemoglobin in the blood of favic patients has lead to the widespread opinion that favism is the result of direct vascular lysis of injured red cells (Arese et al., 1989) . However, we have observed previously that in vitro exposure of rat red cells to divicine does not induce hemolysis in the test tube (McMillan et al., 1993) . Furthermore, spleen weights were increased significantly in   FIG. 4 . Effect of divicine on spleen weight/body weight ratios in rats. Control rats and rats administered divicine hydrochloride (680 mol/kg) were weighed and sacrificed at the indicated time points, and the spleens were excised and weighed. Data points are means Ϯ SEM (n ϭ 3). *Significantly different from control (p Ͻ 0.05).
FIG. 5.
Effect of divicine on blood GSH content in rats. Serial blood samples (75 l) from rats treated with the vehicle and divicine hydrochloride (500 mol/kg) were obtained at the designated time points and the level of GSH was determined against a standard curve using HPLC with electrochemical detection. Data points are means Ϯ SEM (n ϭ 3). *Significantly different from control (p Ͻ 0.05). divicine-treated rats (Fig. 4) , which suggested that red cell removal from the circulation was mediated extravascularly by the reticuloendothelial system. To determine the site(s) of sequestration of divicine-damaged red cells in the rat, and to assess whether the hemotoxicity induced by in vitro exposure to divicine is representative of the damage inflicted upon exposure to divicine in vivo, the disposition of the 51 Cr-tagged red cells was determined after incubation with a hemolytic concentration of divicine (1.4 mM).
Upon readministration to rats, divicine-treated red cells showed an initial rapid disappearance from the blood (Fig. 7A) . This loss of blood radioactivity coincided with a dramatic increase in splenic radioactivity (Fig. 7B) , which was not observed in rats that received the untreated control cells. The level of radioactivity in the spleen remained relatively constant over the course of the experiment. The levels of radioactivity found in the livers of rats given divicine-treated cells were slightly higher than those in controls (Fig. 7B) , and these levels remained constant over the course of the experiment. On a whole-organ basis, the radioactivity in the spleen was 6 to 8 times that in the liver and 20 to 30 times higher when expressed per gram of tissue.
The excretion of 51 Cr in the urine during the first 24 h was higher in divicine-treated animals than in controls. However, the radioactivity excreted over the remainder of the experiment for both treatment and control groups was similar, and accounted for ϳ1 to 2% of the administered doses of radioactivity per day. These excretion rates are consistent with the rate of normal elution of the radiolabel from the red cell (Harrison and Jollow, 1986) . In addition, the sum of the radioactivity in the blood, liver, spleen, and urine was greater than 95% over the first 2 days, and over 80% during the remainder of the study. This observation indicates that other sites of sequestration play only a minor role in the removal of divicine-damaged red cells.
DISCUSSION
The sequelae of favism in susceptible humans, viz., an abrupt, life-threatening loss of red cells following ingestion of fava beans, is a well known phenomenon. The favic crisis usually begins several hours after ingestion of raw or cooked beans and can persist for several days. The clinical condition is characterized by a variety of symptoms including fever, weakness, free hemoglobin in the blood and urine, icterus, enlarged spleen, elevated reticulocyte counts, and renal failure (Arese et al., 1989) . Favism resembles the hemolytic anemia seen in patients who receive certain arylamine drugs such as primaquine and dapsone. It differs in that only low-activity (i.e., Mediterranean) variants of erythrocytic G6PD deficiency appear to be sensitive to fava beans (Beutler, 1978) . Furthermore, the incidence of favism among susceptible individuals is variable. This variability has led to speculation that responsiveness may differ as a function of time, and/or that additional genetic or metabolic factors may be involved in the onset of hemotoxicity (Battistuzzi et al., 1982; Mareni et al., 1984) .
In addition to the change in responsiveness that may occur among susceptible individuals over time, the vicine and convicine content of fava beans may also vary according to where the beans are grown and how they are prepared for consumption (Kattamis et al., 1969) . Thus, the relationship between dose and favic response in susceptible humans is obscure. What is known about the dose-response relationship comes from anecdotal information and clinical case reports. For example, favic responses have been attributed to ingestion of as little as one fava bean (Beutler, 1978) , though typically more substantial amounts are consumed. The marked variability in incidence and the potential that the response could be induced at extremely low exposure has been of major concern for the experimental study of favism. It implies that a trigger mechanism, such as an immune response, could be involved in the onset of hemotoxicity. Thus, it was important to determine if the clinical signs of favism could be reproduced in G6PD-normal rats with no prior exposure to fava beans or their alkaloid constituents.
The present studies demonstrate that the rat responds to divicine administration in a manner similar to that seen in human clinical favism. The survival of 51 Cr-labeled red cells in rats was reduced dramatically within 6 to 12 h after ip administration of divicine. In the rat, this occurred in a dose-dependent manner (Fig. 1) . This response was accompanied by corresponding decreases in the hematocrit (Fig. 2) , and the appearance of hemoglobinurea and reticulocytosis (Fig. 3) .
Clearly, the major difference between our rat model and human favism is the dose of divicine (i.e., Ͼ220 mol/kg) needed to elicit a hemolytic response. While the dose required in Mediterranean-variant humans is undefined, known alkaloid levels in fava beans would suggest that the human dose may be significantly less than that needed in the rat (Arese, 1982) . We presume that the species difference is because rat red cells have normal G6PD activity. Of importance, this rat model may be used to examine the role of G6PD activity and other factors that determine the size of the dose in the rat. This, in turn, may shed some light on the factors that determine the size and variability of the dose in susceptible humans.
The appearance of hemoglobin in the urine and free hemoglobin in the blood of favic patients has led to the concept that intravascular hemolysis of osmotically fragile red cells is responsible for the favic response. This concept, though widely accepted, has been challenged by Arese and co-workers, who reported that divicine-treated cells do not lyse in the test tube. These investigators calculated that intravascular lysis accounts for only about 20% of the total loss of red cells during a favic crisis (Arese et al., 1989) . Although the mechanisms by which hemolytic agents cause a reduction in cellular viability have not yet been elucidated, it is known that damaged red cells are removed by the reticuloendothelial tissues of the spleen and liver. Mildly damaged red cells have been shown to be removed intact, preferentially by the spleen, whereas severely damaged cells, lysed cell fragments, and free hemoglobin are removed by the liver (Rifkind, 1966) . In the present studies, the increase in spleen weight in divicine-treated rats (Fig. 4) and the preferential uptake of radioactivity into the spleen following in vitro exposure of 51 Cr-labeled rat red cells to divicine (Fig. 7) are consistent with splenic sequestration of intact red cells rather than frank intravascular lysis (Jandl et al., 1956; Ultmann and Gordon, 1965; Harrison and Jollow, 1986) .
We have shown previously that divicine is a direct-acting hemolytic agent (McMillan et al., 1993) . That is, incubation of divicine, prepared either synthetically or by enzymatic hydrolysis of its parent glucoside, vicine, with 51 Cr-labeled red cells in vitro caused damage such that the cells were removed extremely rapidly from the circulation after their readministration to isologous rats. In contrast, incubation of red cells with a relatively high concentration of vicine (5 mM) did not induce a hemolytic response, supporting the concept that the parent glucosides are inactive and must be converted to the corresponding aglycones in order to induce hemotoxicity. In the present studies, we have extended these observations to show that the hemotoxicity induced by in vitro exposure to divicine is concentration-dependent (Fig. 6) , with an EC 50 of about 1.5 mM. This in vitro hemotoxic response was characterized by an initial rapid phase of removal of red cells from the circulation followed by a second slow phase. The rate of removal in this second phase was even slower than that seen in control incubates (Fig. 6A) . The initial removal phase is considered to represent the removal of divicine-damaged cells whereas the slow phase reflects the normal removal of younger, presumably undamaged, red cells as they become senescent. This biphasic removal pattern contrasts markedly with the more moderate removal of red cells observed after in vivo exposure to divicine (Fig. 1A) . The slower rate of removal may reflect capacity limitation of the spleen, which becomes overwhelmed by the large number of damaged red cells (both radiolabeled and non-labeled) that are destined for removal from the circulation.
As noted above, the concentration range which defined the hemotoxicity of divicine towards rat red cells (Fig. 6B ) may be considered high relative to that expected in the blood of favic patients (Beutler, 1978) . We do not yet know whether the lesser susceptibility of rat red cells is associated solely with the presence of normal G6PD activity or whether additional, as yet undefined, factors play major roles. It is of note that both the in vivo and in vitro responses were characterized by extremely sharp dose-and concentration-response curves (Figs. 1B and 6B), suggesting the existence of a discrete threshold for hemotoxicity. If the rat model is representative of the human clinical situation, then this observation may explain why G6PD-deficient individuals, who would be expected to have a much lower threshold for hemotoxicity, are susceptible to favism whereas G6PD-normal individuals are resistant. Although this concept is consistent with the susceptibility to favism observed in certain G6PD-deficient humans, it does not provide an explanation for the perplexing variability of favism observed within susceptible G6PD-deficient populations (Battistuzzi et al., 1982) . Additional studies are in progress to determine what other factors might underlie the susceptibility to the hemolytic response induced by divicine.
In summary, we have demonstrated that divicine can induce a favic-like response in rats with normal G6PD activity, and that the hemotoxicity is the result of premature removal of damaged red cells by the spleen. Based on the overall similarities between the responses of rat and human, the rat appears to be a valid model for the study of human favism. Furthermore, the in vitro incubation/in vivo hemolytic response assay will permit an examination of the biochemical alterations that ac-company divicine exposure under toxicologically relevant experimental conditions.
